392 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
VRTX Vertex Pharmaceuticals Incorporated $175.8 $44.93B Downtrend
Article Searches
Vertex Pharmaceuticals Inc (VRTX) CEO & President Jeffrey M Leiden Sold $20.1 million of Shares http://www.gurufocus.com/news/815367/vertex-pharmaceuticals-inc-vrtx-ceo--president-jeffrey-m-leiden-sold-201-million-of-shares Feb 13, 2019 - Vertex Pharmaceuticals Inc (VRTX) CEO & President Jeffrey M Leiden Sold $20.1 million of Shares, Stocks: VRTX, release date:Feb 13, 2019
Is Vertex One Of The Cleanest Growth Stories In Biotech? https://seekingalpha.com/article/4240011-vertex-one-cleanest-growth-stories-biotech?source=feed_sector_healthcare Feb 11, 2019 - Vertex Pharmaceuticals showed a 40% revenue increase from a year ago.A larger patient base boosted profits on the company's three approved CF medications.VRTX share prices have doubled in the last two
The Zacks Analyst Blog Highlights: Gilead, Vertex, Celgene, Alkermes and AVEO http://www.zacks.com/stock/news/352897/the-zacks-analyst-blog-highlights-gilead-vertex-celgene-alkermes-and-aveo?cid=CS-ZC-FT-352897 Feb 07, 2019 - The Zacks Analyst Blog Highlights: Gilead, Vertex, Celgene, Alkermes and AVEO
Vertex Pharmaceuticals Inc (VRTX) CEO & President Jeffrey M Leiden Sold $6 million of Shares http://www.gurufocus.com/news/811682/vertex-pharmaceuticals-inc-vrtx-ceo--president-jeffrey-m-leiden-sold-6-million-of-shares Feb 06, 2019 - Vertex Pharmaceuticals Inc (VRTX) CEO & President Jeffrey M Leiden Sold $6 million of Shares, Stocks: VRTX, release date:Feb 06, 2019
Vertex (VRTX) Q4 Earnings Beat on Solid CF Products Sales http://www.zacks.com/stock/news/352543/vertex-vrtx-q4-earnings-beat-on-solid-cf-products-sales?cid=CS-ZC-FT-352543 Feb 06, 2019 - Vertex's (VRTX) Q4 grows on earnings and revenue beat with rising demand for its CF products. Shares up.
Biotech Stock Roundup: Celgene Tops in Q4, Gilead Disappoints, ALKS & AVEO Sink http://www.zacks.com/stock/news/352335/biotech-stock-roundup-celgene-tops-in-q4-gilead-disappoints-alks-aveo-sink?cid=CS-ZC-FT-352335 Feb 06, 2019 - Key highlights of the week were the fourth-quarter results by biotech bigwigs Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX) and Celgene (CELG).
Vertex Pharmaceuticals Incorporated (VRTX) CEO Jeff Leiden on Q4 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4238486-vertex-pharmaceuticals-incorporated-vrtx-ceo-jeff-leiden-q4-2018-results-earnings-call?source=feed_sector_healthcare Feb 06, 2019 -
Vertex Pharmaceuticals Incorporated 2018 Q4 - Results - Earnings Call Slides https://seekingalpha.com/article/4238373-vertex-pharmaceuticals-incorporated-2018-q4-results-earnings-call-slides?source=feed_sector_healthcare Feb 05, 2019 - The following slide deck was published by Vertex Pharmaceuticals Incorporated in conjunction with their 2018 Q4 earnings call.
Translate Bio Suffers Clinical Hold But It Had Gone Through This Issue Before https://seekingalpha.com/article/4238213-translate-bio-suffers-clinical-hold-gone-issue?source=feed_sector_healthcare Feb 05, 2019 -
Regeneron (REGN) to Report Q4 Earnings: Is a Beat in Store? http://www.zacks.com/stock/news/351772/regeneron-regn-to-report-q4-earnings-is-a-beat-in-store?cid=CS-ZC-FT-351772 Feb 04, 2019 - Strong Eylea and Dupixent sales are likely to propel better-than-expected results for Regeneron (REGN) when it reports fourth-quarter results.

Pages: 123456...40

Page 1>

Related Companies

Name Exchange Price Mkt Cap
SHPG Shire plc NASDAQ $176.25 $46.08B
ZTS Zoetis Inc. NYSE $88.3 $42.55B
REGN Regeneron Pharmaceuticals, Inc. NASDAQ $386.665 $41.78B
CELG Celgene Corporation NASDAQ $87.23 $61.35B
AGN Allergan plc. NYSE $184.29 $62.56B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Vertex Pharmaceuticals Incorporated
VRTX - Google Finance https://www.google.com/finance?q=VRTX Industry related info and international coverage Summary News
VRTX - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=VRTX Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options